HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Animal models of corneal endothelial dysfunction to facilitate development of novel therapies.

Abstract
Progressive corneal endothelial disease eventually leads to corneal edema and vision loss due to the limited regenerative capacity of the corneal endothelium in vivo and is a major indication for corneal transplantation. Despite the relatively high success rate of corneal transplantation, there remains a pressing global clinical need to identify improved therapeutic strategies to address this debilitating condition. To evaluate the safety and efficacy of novel therapeutics, there is a growing demand for pre-clinical animal models of corneal endothelial dysfunction. In this review, experimentally induced, spontaneously occurring and genetically modified animal models of corneal endothelial dysfunction are described to assist researchers in making informed decisions regarding the selection of the most appropriate animal models to meet their research goals.
AuthorsSangwan Park, Brian C Leonard, Vijay Krishna Raghunathan, Soohyun Kim, Jennifer Y Li, Mark J Mannis, Christopher J Murphy, Sara M Thomasy
JournalAnnals of translational medicine (Ann Transl Med) Vol. 9 Issue 15 Pg. 1271 (Aug 2021) ISSN: 2305-5839 [Print] China
PMID34532408 (Publication Type: Journal Article, Review)
Copyright2021 Annals of Translational Medicine. All rights reserved.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: